FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for Voriconazole from Zydus Lifesciences Limited, updating the approval for this generic antifungal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Disseminated Candidiasis
• Esophageal Candidiasis
• Invasive Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

SUPPL AP for VORICONAZOLE (VORICONAZOLE)